These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
671 related articles for article (PubMed ID: 29927694)
1. DNA methylation biomarkers for head and neck squamous cell carcinoma. Zhou C; Ye M; Ni S; Li Q; Ye D; Li J; Shen Z; Deng H Epigenetics; 2018; 13(4):398-409. PubMed ID: 29927694 [TBL] [Abstract][Full Text] [Related]
3. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets. Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443 [TBL] [Abstract][Full Text] [Related]
4. Analysis of methylation-driven genes for predicting the prognosis of patients with head and neck squamous cell carcinoma. Pan Y; Song Y; Cheng L; Xu H; Liu J J Cell Biochem; 2019 Dec; 120(12):19482-19495. PubMed ID: 31264288 [TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of DNA methylation and mRNA expression profiles to identify key genes in head and neck squamous cell carcinoma. Jin Y; Qin X Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894857 [TBL] [Abstract][Full Text] [Related]
6. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma. Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463 [TBL] [Abstract][Full Text] [Related]
7. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods. Jin Y; Yang Y Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688 [TBL] [Abstract][Full Text] [Related]
8. Synthetic Evaluation of MicroRNA-1-3p Expression in Head and Neck Squamous Cell Carcinoma Based on Microarray Chips and MicroRNA Sequencing. Chen Y; Liu M; Jin H; Peng B; Dai L; Wang S; Xing H; Wang B; Wu Z Biomed Res Int; 2021; 2021():6529255. PubMed ID: 34485523 [TBL] [Abstract][Full Text] [Related]
9. The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma. Zhou C; Li J; Li Q; Liu H; Ye D; Wu Z; Shen Z; Deng H J Clin Lab Anal; 2019 Jun; 33(5):e22873. PubMed ID: 30843252 [TBL] [Abstract][Full Text] [Related]
10. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis. Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma. Zhang F; Liu Y; Yang Y; Yang K BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731 [TBL] [Abstract][Full Text] [Related]
12. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
13. Characterization of a prognostic four‑gene methylation signature associated with radiotherapy for head and neck squamous cell carcinoma. Ma J; Li R; Wang J Mol Med Rep; 2019 Jul; 20(1):622-632. PubMed ID: 31180552 [TBL] [Abstract][Full Text] [Related]
14. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis. Yi L; Luo P; Zhang J J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184 [TBL] [Abstract][Full Text] [Related]
15. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue. Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813 [TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of differentially methylated expressed genes and site-specific methylation as potential prognostic markers in head and neck cancer. Bai G; Song J; Yuan Y; Chen Z; Tian Y; Yin X; Niu Y; Liu J J Cell Physiol; 2019 Dec; 234(12):22687-22702. PubMed ID: 31131446 [TBL] [Abstract][Full Text] [Related]
17. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer. Schmitt K; Molfenter B; Laureano NK; Tawk B; Bieg M; Hostench XP; Weichenhan D; Ullrich ND; Shang V; Richter D; Stögbauer F; Schroeder L; de Bem Prunes B; Visioli F; Rados PV; Jou A; Plath M; Federspil PA; Thierauf J; Döscher J; Weissinger SE; Hoffmann TK; Wagner S; Wittekindt C; Ishaque N; Eils R; Klussmann JP; Holzinger D; Plass C; Abdollahi A; Freier K; Weichert W; Zaoui K; Hess J Int J Cancer; 2019 Dec; 145(12):3299-3310. PubMed ID: 31135957 [TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of methylation and transcriptome identifies a novel risk model for diagnosis, prognosis, and immune characteristics in head and neck squamous cell carcinoma. Zhang JW; Gao XL; Li S; Zhuang SH; Liang QW Mol Genet Genomics; 2024 Jul; 299(1):71. PubMed ID: 39031208 [TBL] [Abstract][Full Text] [Related]
19. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma. Song D; Tian J; Han X; Li X Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165 [TBL] [Abstract][Full Text] [Related]
20. Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma. Cao Y; Green K; Quattlebaum S; Milam B; Lu L; Gao D; He H; Li N; Gao L; Hall F; Whinery M; Handley E; Ma Y; Xu T; Jin F; Xiao J; Wei M; Smith D; Bornstein S; Gross N; Pyeon D; Song J; Lu SL Clin Epigenetics; 2018; 10():43. PubMed ID: 29636832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]